Welcome to the Global Alliance for Rapid Diagnostics (GARD)!
We are a multidisciplinary group of researchers and practitioners from around the world (peer-to-peer network of equals) committed to improving global health by reducing infectious diseases through early diagnosis.
Vision: Prevent illness, save lives, and improve quality of life through rapid diagnostics.
Mission: To develop portable, affordable, accessible, available, and globally deployable nano-enabled biosensor technologies for rapid and early detection of infectious and antimicrobial resistant diseases in populations who need help the most but can afford the least.
Output: Publications and presentations, joint funding, capacity building (workshops and lectures), student research, and faculty/student training, global symposia, global/local strategies
"A dollar or a minute may not solve much, but a pool of dollars or a pool of minutes may be enough to impact someone’s life." Dr. Evangelyn C. Alocilja, Founder, GARD
"Defend the weak and the fatherless; uphold the cause of the poor and the oppressed." (Psalm 82:3)
Download the schedule in English.
Download the Innovation Challenge flyer here.
Apply to be a GARD Representative. Find a full descriptions of the various roles of GARD Representative's here.
Connect with us! Join our slack workspace
Download the general program here.
Download the Day 1 Innovation Challenge schedule here.
Download the Day 1 East and Southeast Asia schedule here.
Download the Day 1 Africa schedule here.
Download the Day 1 Latin America schedule in English and in Spanish.
Download the Day 2 East and Southeast Asia schedule here.
Download the Day 2 South Asia schedule here.
Download the Day 2 Americas schedule here.
Pre-recorded talks will be visible during the forum. To find the directory of posters visit here. To find the directory of pre-recorded talks visit here.
Thank you to our 2021 sponsors!
If you are interested in being a sponsor and exhibitor, please email firstname.lastname@example.org.
GARD-related Peer-reviewed Journal Publications:
- Briceno RK, Sergent SR, Benites SM, Alocilja EC. 2019. Nanoparticle-based Biosensing Assay for Universally Accessible Low-Cost TB Detection with Comparable Sensitivity as Culture. Diagnostics, 9:222 (14 p).
- Yrad et al., 2019. Visual Detection of Dengue-1 RNA Using Gold Nanoparticle-Based Lateral Flow Biosensor. Diagnostics, 9:74-88.
- Franco et al., 2019. DNA-based electrochemical nanobiosensor for the detection of Phytophthora palmivora (Butler) Butler, causing black pod rot in cacao (Theobroma cacao L.) pods. Physiology and Molecular Plant Pathology, 107: 14-20.
- Bhusal et al., 2019. Nanoparticle-based Biosensing of Tuberculosis, an Affordable and Practical Alternative to Current Methods. Biosensors, 9(1):1-11.
- Gordillo et al., 2018. Magnetic Nanoparticle-Based Biosensing Assay Quantitatively Enhances Acid-Fast Bacilli Count in Paucibacillary Pulmonary Tuberculosis. Biosensors, 8(4):128-141.
- Zeeshan et al., 2018. Impedance and Magnetohydrodynamic Measurements for Label Free Detection and Differentiation of E. coli and S. aureus using Magnetic Nanoparticles. IEEE Transactions on NanoBioscience, 17(4):443-448.
- Lim et al., 2017. Alocilja Magnetic Nanoparticles Efficiently Capture Escherichia coli O157:H7 Isolates. Philippine Journal of Pathology Open Access, 2(2):47-49.
- Contreras et al., 2016. Fabrication of a nanoparticle-based sensor for the detection of dengue virus-3 in Aedes aegypti. International Journal of Sciences: Basic and Appliece Research, 26(3):138-157.
International Blog: http://nanotecnologiainve.wixsite.com/nano
GARD was founded by Dr. Evangelyn C. Alocilja in 2016 after seeing the need for affordable and accessible diagnostic technologies in resoure-limited populations.
Members are from the following countries (more to come):
If interested in becoming a member, please contact Dr. Evangelyn Alocilja at email@example.com.